A RCT With Factorial Design to Compare Safety and Efficacy of 2 Capsules of the Indian Polycap Versus a Single Capsule Along With or Without Oral Potassium Among Patients With Stable Cardiovascular Disease.

Trial Profile

A RCT With Factorial Design to Compare Safety and Efficacy of 2 Capsules of the Indian Polycap Versus a Single Capsule Along With or Without Oral Potassium Among Patients With Stable Cardiovascular Disease.

Completed
Phase of Trial: Phase III/IV

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin; Potassium
  • Indications Atherosclerosis; Cardiovascular disorders; Coronary artery disease; Embolism and thrombosis; Hypertension; Ischaemic heart disorders; Myocardial infarction; Stroke
  • Focus Therapeutic Use
  • Acronyms TIPS-2
  • Most Recent Events

    • 21 Apr 2012 Results presented at the 18th World Congress of Cardiology.
    • 01 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top